Kore Private Wealth’s Mesoblast MESO Stock Holding History

Kore Private Wealth’s Portfolio MESO Stock Details MESO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,000	Closed	-$22K	–	758
2020 Q2	$22K	Hold	1,000	–	–	﹤0.01%	632
2020 Q1	$9K	Hold	1,000	–	–	﹤0.01%	709
2019 Q4	$15K	Buy	+1,000	New	+$12.7K	﹤0.01%	682
2019 Q2	–	Sell	-1,000	Closed	-$11K	–	570
2019 Q1	$11K	Buy	+1,000	New	+$9.12K	﹤0.01%	617

Other funds holding MESO

MGIM

M&G Investment Management London, United Kingdom $28.2B AUM 25.87% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Penbrook Management New York $132M AUM 29.91% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

PCM

Princeton Capital Management Red Bank, New Jersey $367M AUM 45.24% 1-Year Est. Return

Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

OAMG

Odey Asset Management Group London, United Kingdom $381M AUM 45.36% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Kore Private Wealth's MESO Position: Q3 2020 in Review

Kore Private Wealth sold out of Mesoblast (MESO) in Q3 2020, closing a stake of 1,000 shares — an estimated $22K sold.

Kore Private Wealth first reported a position in MESO in Q1 2019 and held it in 4 quarters. The position peaked at $22K in Q2 2020. 52 funds tracked by Wall St. Rank hold MESO as of Q3 2020.

Kore Private Wealth reported no remaining Mesoblast position as of Q3 2020 after selling out during the quarter.
Kore Private Wealth sold 1,000 Mesoblast shares in Q3 2020, an estimated $22K.
Kore Private Wealth first reported a position in Mesoblast in Q1 2019 and held it in 4 quarters.
Kore Private Wealth's Mesoblast position peaked at $22K in Q2 2020.
52 funds tracked by Wall St. Rank held Mesoblast as of Q3 2020.

Based on Kore Private Wealth's 13F filing for Q3 2020, filed 13 Nov 2020.